| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MC.20819 |
| P698 | PubMed publication ID | 21739480 |
| P2093 | author name string | Yi Wang | |
| Guangfu Jin | |||
| Hongbing Shen | |||
| Hongxia Ma | |||
| Jing Dong | |||
| Juncheng Dai | |||
| Yongqian Shu | |||
| Yue Jiang | |||
| Zhibin Hu | |||
| Shiyang Pan | |||
| Lingmin Hu | |||
| Wenping Chen | |||
| P2860 | cites work | Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays | Q24816878 |
| Global cancer statistics, 2002 | Q27860562 | ||
| Genome maintenance mechanisms for preventing cancer | Q28131737 | ||
| Assessing the probability that a positive report is false: an approach for molecular epidemiology studies | Q29616285 | ||
| Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer | Q33258084 | ||
| Mechanisms of resistance to cisplatin | Q34282241 | ||
| Modulation of DNA damage/DNA repair capacity by XPC polymorphisms | Q36478743 | ||
| Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation | Q36790428 | ||
| Associations between XPC polymorphisms and risk of cancers: A meta-analysis | Q37260828 | ||
| Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer | Q37474271 | ||
| Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study | Q40845183 | ||
| Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy | Q43406715 | ||
| A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population | Q44765135 | ||
| Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer | Q44995386 | ||
| ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma | Q45012084 | ||
| Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. | Q45057544 | ||
| DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer | Q46052831 | ||
| XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy | Q47405891 | ||
| Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population. | Q53299875 | ||
| Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. | Q53577396 | ||
| An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. | Q53964801 | ||
| Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer | Q59274335 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 546-552 | |
| P577 | publication date | 2011-07-07 | |
| P1433 | published in | Molecular Carcinogenesis | Q15724597 |
| P1476 | title | Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis | |
| P478 | volume | 51 |
| Q26750858 | A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis |
| Q61802209 | ATM rs189037 (G > A) polymorphism increased the risk of cancer: an updated meta-analysis |
| Q38070069 | Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies |
| Q34438260 | Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients. |
| Q44006358 | Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients |
| Q34909764 | Association of the ATM gene polymorphisms with papillary thyroid cancer |
| Q28539722 | Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer |
| Q27025537 | Base excision repair and cancer |
| Q41705402 | Correlation between polymorphisms in DNA mismatch repair genes and the risk of primary hepatocellular carcinoma for the Han population in northern China |
| Q38315516 | DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences |
| Q34776412 | Effect of single nucleotide polymorphism Rs189037 in ATM gene on risk of lung cancer in Chinese: a case-control study |
| Q36069834 | Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma |
| Q33912148 | Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis |
| Q64983584 | Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population. |
| Q34097695 | Genome-wide association study identifies variants in PMS1 associated with serum ferritin in a Chinese population |
| Q88377288 | Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients |
| Q51721581 | Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients. |
| Q31170960 | Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients |
| Q91663575 | Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients |
| Q87003212 | Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer |
| Q26743378 | Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer |
| Q38171397 | The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis |
| Q38632738 | The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapy |
| Q35700740 | The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients. |
| Q30381884 | The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC |
| Q36386267 | XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies |
| Q35173399 | XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects |
Search more.